Navigation Links
BioCis Pharma Starts a Phase I Clinical Trial With a New Cancer Drug
Date:5/28/2009

d is an innovative drug development company developing drug therapies based on a novel, patented therapeutic principles that target unmet medical needs in substantial therapeutic markets including inflammation, allergy, and cancer. The company's main investors are Karolinska Development AB (publ.), Finnish Industry Investment Ltd., and Etra Invest Oy.

http://www.biocis.com

Contacts:

Dr. Lasse Leino, CEO, BioCis Pharma Ltd., mobile phone +358-40-849-4694, lasse.leino@biocis.com


'/>"/>
SOURCE BioCis Pharma Ltd
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Kinex Pharmaceuticals To Present at ASCO 2009 Annual Meeting
2. TRACON Pharmaceuticals Small Molecule TRC102 and Antibody TRC105 to be Presented at ASCO 2009
3. PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA
4. New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI)
5. Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data in Patients With Schizophrenia
6. PARI Pharmas Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS
7. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
8. Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
9. Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain
10. Tris Pharma Announces Acceptance of Its First Two NDAs
11. Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... , NEW YORK, Nov. 20 Reportlink... is available in its catalogue. ,, Global Mark... http://www.reportlinker.com/p0164742/Global-Mark...m_source=prnewswire&utm_medium=pr&utm_camp...d Reproduction covers the U.S., 15 Countries in Eu...
(Date:11/20/2009)...MINNEAPOLIS, Nov. 20 Bio...lts for its first quarter ended September 30, 2009...ed share, on revenues of $3,263,000. This compare...d share, on revenues of $3,168,000 for the first q... quarter results, Biotel President and CEO Steve S...
(Date:11/20/2009)... FRANKLIN LAKES, N.J., Nov. 20 /PRNewswire-FirstCa... BDX ) today announced the completion of its acqui...ased company that develops and manufactures molecu..., In May 2009, BD and HandyLab announced an excl...e molecular assays on the HandyLab Jaguar(TM) plat...
Breaking Medicine Technology:Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2Biotel Announced Profitable First Quarter Ended September 30, 2009 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Partnership for Prescription Assistance Prepared to Help Pennsylvania Workers Hurt by Recession 52593 1Partnership for Prescription Assistance Prepared to Help Pennsylvania Workers Hurt by Recession 52593 2Partnership for Prescription Assistance Prepared to Help Pennsylvania Workers Hurt by Recession 52593 3Partnership for Prescription Assistance Prepared to Help Pennsylvania Workers Hurt by Recession 52593 4As the Government Continues to Work Toward Health Care Reform Medtipster is Providing a Free Solution to Rising Health Care Costs for Americans Right 52591 1As the Government Continues to Work Toward Health Care Reform Medtipster is Providing a Free Solution to Rising Health Care Costs for Americans Right 52591 2Human cells secrete cancer killing protein UK study finds 52589 1Human cells secrete cancer killing protein UK study finds 52589 2
...gimen yielded nearly double SVR rate compared to s... protease inhibitor SCH 900518 presented at EASL a...Schering-Plough Corporation (NYSE: SGP ) today r...dy showed boceprevir, its investigational oral hep...eginterferon alfa-2b and ribavirin, significantly ...
...ducation Online Activity and Podcast for Nurses an... lymphoblastic leukemia (ALL) is a complex heterog... in the treatment of pediatric patients, is often ...fessionals who treat adult patients with ALL to ma...e of factors affecting management options for this...
Other Medicine Technology:Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 2Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 3Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 4Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 5Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 6Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 7Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 8Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 9Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 10Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 11Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 12Expert Insights in Acute Lymphoblastic Leukemia: Current Challenges and Future Directions 2
(Date:11/20/2009)...ov. 20 Following a recall by Unile...d from sale Shedd,s Country Crock ® Side Dish...y Crock ® Side Dishes DELUXE Four Cheese Past...e following code dates and UPCs are affected: ,... Cheddar Broccoli Rice 21 oz, UPC 027400218316, Be...
(Date:11/20/2009)..., Nov. 20 Rates of infec...ked in late October, but the pandemic flu virus co... age groups, including the elderly, according to a...E: DGX ), the world,s leading provider of diagno...its most recent Quest Diagnostics Health Trends(TM...
(Date:11/20/2009)...v. 20 Centene Corporat...esent at the Bank of America Merrill Lynch 2009 Cr... the Crowne Plaza Hotel Times Square in New York C...r 2nd at 8:30 a.m. Eastern Time. Investors and oth...cast of Centene,s presentation at: http://www.ver...
(Date:11/20/2009)....C., Nov. 20 Samuel Gla...efine what it means to be "happy" during the holid...pecialty in family counseling and chair of the Dep...ladding says research shows that it is the pressur... depression during the holidays. ,, That,s why ...
(Date:11/20/2009)...ov. 20 SIRIUS XM Radio ...adcast Doctor Radio Reports: What Every Women N...l hosted by veteran journalist Perri Peltz. ,,...819/NYTU044LOGO ) ,, Doctor Radio Reports: W...ll air November 21 live at 10:00 am ET on Doctor...
Breaking Medicine News(10 mins):Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5
...07 The Journal of the American Dental Association...ournals today in publishing a global theme issue o...collaborative effort among the worlds biomedical p...he world of articles on povertys devastating effec...
...wswire/ - IntelliPharmaCeutics Ltd. (the,"Company"... generic drug,commercialization activities. In la...any,s operating,affiliate IntelliPharmaCeutics Cor...plication (known as an ANDA) for a,drug product it...
...ng of Innovative Hypotheses, NEW YORK, Oct. 22 T...e selection of its 6th round of Novel Research,Gra...primed to explore,entirely new ideas on why the lu...oneering innovative lupus research. The outlay of...
...fth largest journal publisher, is proud to be part...uman Development launched today by the Council of ...s to raise awareness and stimulate interest and de... simultaneously publish papers on this topic, enab...
...er 22, 2007) A new study shows that obstacles to ... vary with age. The study presented at CHEST 2007,... of the American College of Chest Physicians (ACCP...e 65 reported cigarette cost and tobacco odor as r...
...Autism in California Lack Proper Healthcare Covera...,Area Chapter of Autism Speaks today announced the...slative Blue Ribbon Commission on,Autism,s recomme... the California State Legislature and Governor,Arn...
Other Medicine News:Health News:Journal of the American Dental Association spotlights poverty 2Health News:IntelliPharmaCeuitics Ltd. Announces Generic Drug Commercialization Activities 2Health News:New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs 2Health News:New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs 3Health News:New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs 4Health News:9 SAGE journals participate in global theme issue on poverty and human development 2Health News:Age affects motivation for quitting smoking 2Health News:San Francisco Bay Area Autism Speaks Chapter Endorses Blue Ribbon Commission on Autism Recommendations for Equitable Insurance Coverage for Children With Autism 2Health News:San Francisco Bay Area Autism Speaks Chapter Endorses Blue Ribbon Commission on Autism Recommendations for Equitable Insurance Coverage for Children With Autism 3
Liquid Trap
...d Transfer Kit High resolution ,transfer of DNA an...lary transfer allows for,alkaline buffer transfers... hours. , Economical Reusable blotting device re...refill packs available., Compact ,TurboBlotter h...
... using the Antigen-Antibody Pens-Using a proprieta...eveloped specialized fountain pens, called Antigen...deliver or write/mark the blotting membranes in an...tigen-bonded colored dyes helps to see antigen bei...
... using the Antigen-Antibody Pens-Using a proprieta...eveloped specialized fountain pens, called Antigen...deliver or write/mark the blotting membranes in an...tigen-bonded colored dyes helps to see antigen bei...
Medicine Products: